There is evidence that FAIM2 expression may increase susceptibility to type 2 diabetes associated with obesity [52] and to obstructive sleep apnea-related cardiac injury [53], thus, the FAIM2 downregulation (found in TRA subjects) appears to bear favorable effects. Here, FAIM2 is linked to obesity due to melanocortin 4 receptor deficiency.